We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Technology to Treat Arrhythmias

By HospiMedica staff writers
Posted on 21 Jul 2005
A new digital magnetic navigation system helps doctors to remotely steer small catheters throughout the heart and surrounding vessels to treat cardiac arrhythmias.

This Stereotaxis technology uses magnets outside the body to guide catheters inside the heart by remote control. More...
Cardiologists can then precisely position the catheters via remote control to reach the exact location where the heart is malfunctioning. The catheter is then activated to ablate or treat the area in the heart by disrupting the abnormal signals.

Cardiac arrthymias are caused by a change in the normal sequence of electrical impulses in the heart. This can cause the heart to pump less effectively. If arrhythmias last for some time, they may cause the heart rate to be too slow or too fast or the heart rhythm to be erratic.

"Stereotaxis offers us the ability to guide and place a catheter anywhere in the heart or surrounding vessels, including incredibly difficult or previously inaccessible locations,” noted William Katsiyiannis, M.D., a cardiologist with the Minneapolis Heart Institute at Abbott Northwestern Hospital (Minneapolis, MN, USA). "This technology has the potential to change how we treat patients who require interventional cardiac procedures.” The Minneapolis Heart Institute is recognized internationally as one of the world's leading heart institutes.

The Stereotaxis laboratory is located in Abbott Northwestern Hospital. The Stereotaxis system was developed by Stereotaxis, Inc. (St. Louis, MO, USA).





Related Links:
Abbott Northwestern
Stereotaxis

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.